Enhanced Access to Affordable Medicines Act of 2022
Official title: A bill to amend the Federal Food, Drug, and Cosmetic Act to clarify the conditions under which the Secretary of Health and Human Services can approve generic d… Show full official titleShow less
Official title: A bill to amend the Federal Food, Drug, and Cosmetic Act to clarify the conditions under which the Secretary of Health and Human Services can approve generic drug applications with labeling temporarily different than the brand name drug, and for other purposes.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Enhanced Access to Affordable Medicines Act of 2022
This bill specifies that the Food and Drug Administration may approve generic drugs with different labels than the brand-name versions if, among other requirements, a revised label for the brand-name drug is approved within 90 days of when the generic is otherwise eligible for approval.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 4351: Enhanced Access to Affordable Medicines Act of 2022. 117th Congress. Open America. https://openamerica.io/bill/117-S-4351/
"S. 4351: Enhanced Access to Affordable Medicines Act of 2022." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-4351/.
S. 4351, 117th Cong. (2026), https://openamerica.io/bill/117-S-4351/.
[S. 4351: Enhanced Access to Affordable Medicines Act of 2022](https://openamerica.io/bill/117-S-4351/)